ESHOS Director-at-Large David Eagle, MD, New York Cancer & Blood Specialists, who shares the importance of grassroots advocacy efforts though day-to-day practice and participation in state-based organizations to furthering health equity and patient-centered care.

The Federal Trade Commission unanimously launched a formal inquiry into the business practices of the prescription drug middleman industry—known as pharmacy benefit managers (PBMs)—in early June 2022 due to the overwhelming response of more than 24,000 public comments during their request for information.

Matt Devino, MPH, Director, Cancer Care Delivery & Health Policy, Association of Cancer Care Centers , and President of the Empire State Hematology & Oncology Society, Rahul Seth, DO, discuss why every voice is critical in grassroots advocacy efforts on both the federal and state level, and how cancer professionals who moonlight as patient advocates can help improve access to care and reduce financial toxicity for people living with cancer.